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The Q-cycle mechanism of the bc1 complex explains how the electron transfer from ubihydroquinone (quinol, QH2) to cytochrome
(cyt) c (or c2 in bacteria) is coupled to the pumping of protons across the membrane. The efficiency of proton pumping depends on the
effectiveness of the bifurcated reaction at the Qo-site of the complex. This directs the two electrons from QH2 down two different
pathways, one to the high potential chain for delivery to an electron acceptor, and the other across the membrane through a chain
containing heme bL and bH to the Qi-site, to provide the vectorial charge transfer contributing to the proton gradient. In this review, we
discuss problems associated with the turnover of the bc1 complex that center around rates calculated for the normal forward and reverse
reactions, and for bypass (or short-circuit) reactions. Based on rate constants given by distances between redox centers in known
structures, these appeared to preclude conventional electron transfer mechanisms involving an intermediate semiquinone (SQ) in the Qo-site
reaction. However, previous research has strongly suggested that SQ is the reductant for O2 in generation of superoxide at the Qo-site,
introducing an apparent paradox. A simple gating mechanism, in which an intermediate SQ mobile in the volume of the Qo-site is a necessary
component, can readily account for the observed data through a coulombic interaction that prevents SQ anion from close approach to heme bL when
the latter is reduced. This allows rapid and reversible QH2 oxidation, but prevents rapid bypass reactions. The mechanism is quite natural, and is well
supported by experiments in which the role of a key residue, Glu-295, which facilitates proton transfer from the site through a rotational displacement,
has been tested by mutation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Q-cycle; bc1 complex; Proton circuit; Rhodobacter sphaeroides; Qo-site; Superoxide; –PEWY–spanAbbreviations: bc1 complex, ubiquinol:cytochrome c oxidoreductase (EC
1.10.2.2); bL and bH, low- and high-potential hemes of cytochrome b,
respectively; cyt, cytochrome; Em,(pH), midpoint redox potential at pH indicated
(pH 7 assumed if not indicated); ESEEM, electron spin echo envelope
modulation spectroscopy; ISP, Rieske iron–sulfur protein; ISPH, reduced ISP;
ISPox, oxidized, dissociated ISP; MOA-inhibitors, inhibitors with E-β-
methoxyacrylate or similar group as pharmacophore; P-phase, N-phase, aqueous
phases in which the sign of the transmembrane proton gradient is positive or
negative, respectively; PDB, Protein Data Bank; Q, oxidized form of
ubiquinone; QH2, reduced form (hydroquinone, quinol) of ubiquinone; QH
U,
QU−, protonated and deprotonated forms of semiquinone; Qi-site (Qo-site),
quinone reducing (quinol oxidizing) site of bc1 complex; Rb., Rhodobacter; RC,
photosynthetic reaction center; SQ, semiquinone (with protonation state
unspecified); UHDBT, 5-undecyl-6-hydroxy-4,7-dioxobenzothiazol; UHNQ,
2-undecyl-3-hydroxy-1,4-naphthoquinone
⁎ Corresponding author. Department of Biochemistry, 419 Roger Adams Lab,
600 S. Mathews Ave., Urbana, IL 61801, USA. Tel.: +1 217 333 2043; fax: +1
217 244 6615.
E-mail address: a-crofts@life.uiuc.edu (A.R. Crofts).
0005-2728/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2006.02.0091. Introduction
The bc1 complex (Complex III of the mitochondrial respi-
ratory chain) operates through a Q-cycle mechanism (reviewed
in [1–4]). The key feature of this mechanism is the reaction at the
Qo-site in which ubihydroquinone (quinol, QH2) is oxidized.
The two electrons from QH2 are passed to two different electron
transport chains — the first to a high potential chain of the
Rieske iron sulfur protein (ISP), cyt c1, cyt c (or c2 in bacteria),
and a terminal oxidant. The second electron is transferred to a
low potential chain of hemes bL, bH and the Qi-site, and crosses
the membrane, to contribute to both the electrical and chemical
work of the proton gradient. It has generally been consi-
dered that the reaction proceeds through separate 1-electron
steps, with generation of an intermediate SQ. However, as
discussed further below, the viability of schemes involving
Fig. 1. The modified Q-cycle. Schematic model showing the redox centers
(hemes bH and bL in cyt b, heme c1 in cyt c1, and the 2Fe–2S cluster in ISP), the
electron transfer pathways connecting them (solid blue arrows), the binding and
unbinding of substrates and products (QH2, Q (filled broad arrows) at the Qo-
and Qi-sites, and cyt c at the interface on cyt c1),and the release and uptake of
protons (solid red arrows). The membrane is indicated by purple dashed lines,
the cyt b subunit by a dashed cyan box, the ISP subunit by a pale-blue dashed
circle, the cyt c1 subunit by a dashed pink circle, and cyt c by a dashed red circle.
The Qo- and Qi-sites are indicated by the semiquinone intermediates. Inhibitors
discussed in the text are indicated by numbers at arrows pointing to the affected
site as follows: at the Qo-site, 1, 2, 3,-stigmatellin, alkyl-HDBTs, and UHNQ,
which H-bond to ISPH; 4, 5, 6, myxothiazol, other MOA-type inhibitors, and
famoxadone, which H-bond to the backbone NH of the –PEWY– glutamate; at
the Qi-site, 7, 8, antimycin and NQNO.
1020 A.R. Crofts et al. / Biochimica et Biophysica Acta 1757 (2006) 1019–1034significant occupancy of the SQ state has recently been
challenged.
Since the bifurcation is essential for proton pumping, a
perennial question has been how the site operates to prevent both
electrons passing down the more favored pathway, to the high
potential chain, to decouple this process. A second question
relates to a design failure of the bc1 complex. When electrons
back-up in the low potential chain, the Qo-site functions to
reduce O2 to superoxide, the precursor of reactive oxygen spe-
cies that lead to DNA and protein damage and cause cellular
aging and death [5]. How does the mechanism minimize this
deleterious reaction and other potential bypass reactions?
In this brief review, we will first provide an overview of the
Q-cycle and its operation as a proton-pumping machinery, and
address recent advances in our understanding of the critical Qo-
site reaction. This will entail a brief survey of the kinetic, spec-
troscopic, structural, and theoretical tools available, and the use
of these to set constraints on viable mechanisms, especially with
respect to transfer of the first electron, which seems to be the rate
determining process. We will then discuss the properties of the
second electron transfer, the role of the SQ intermediate, and the
different strategies that have been suggested to explain how the
bypass reactions are minimized. Finally, we will discuss a me-
chanism incorporating coulombic gating that accounts for the
peculiarities of the Qo-site reaction in the context of a model
previously proposed [6].
2. The modified Q-cycle
The bifurcation of QH2 oxidation, the reaction at the heart of
the Q-cycle, was first recognized by Wikstron and Berden [7] as
an explanation for the phenomenon of “oxidant-induced reduc-
tion of cytochrome b”[8]. It was Mitchell's genius to incorporate
this reaction into the proton-motive Q-cycle [9,10] by directing
one electron across the membrane to reduce ubiquinone
(quinone, Q) on the other side. He named the two quinone-
processing sites Qo and Qi, to differentiate whether the H
+ came
out on oxidation of QH2, or in on reduction of Q. Garland [11]
recognized that a “stand-alone” enzyme would need to deliver
two electrons to the Qi-site, requiring two turnovers of the Qo-
site for net oxidation of 1 QH2, and called this a modified Q-
cycle. Mitchell [10] discussed many variants of the Q-cycle, and
laid down some of the thermodynamic constraints, but the expe-
rimental evidence available did not allow discrimination bet-
ween these until the early 1980s. Detailed kinetic studies in
chromatophores (the re-sealed invaginations of the inner bac-
terial membranes of photosynthetic bacteria, produced by me-
chanical disruption) showed that the modified Q-cycle could
account for the paradoxical behavior observed in this system
[12,13] (reviewed in [4]). The version shown in Fig. 1 is a
consensus Q-cycle adopted by most workers in the field, and is
supported by an extensive set of kinetic and thermodynamic data
for the partial processes [1,14]. The mechanism is also now
strongly supported by structures [15,16] (reviewed in [17]), all
of which show the redox centers, and their organization with
respect to membrane topology, predicted from these earlier
experiments.Proton pumping is achieved indirectly by movement of two
negative charges across the membrane, carried by the electrons
passing through the b-heme chain from Qo to Qi sites, and by
release or uptake of H+, respectively, on oxidation or reduction
of quinone, to give an overall yield of 2H+ pumped for each
QH2 oxidized:
QH2 þ 2cyt cþ þ 2HþN ⇆ Qþ 2cyt cþ 2HþP þ 2HþP ðscalarÞ
In chromatophores, the electrogenic processes can be fol-
lowed through the electrochromic carotenoid changes, which
provide a “membrane voltmeter” function [18], and this con-
venience has allowed a detailed matching of electrogenic events
to partial processes [12,14,19,20]. By careful correction of ab-
sorbance changes in the cytochrome α-band region for con-
tributions from carotenoid changes [21], this approach was
extended to measurement of driving forces from electron trans-
fer during development of the proton gradient in the coupled
steady-state [22–24]. Under static head conditions, the poise
of the electron transfer chain was close to that expected from
the modified Q-cycle in equilibrium with the proton gradient,
Fig. 2. Model of the ES-complex, showing QH2 with H-bonds to His-161 of ISP
and Glu-272 of cyt b. Model based in the structure containing stigmatellin, in
which ubihydroquinone has been modeled in place of the inhibitor. The electron
transfer distance is shown as ∼7 Å (the equivalent bond in the stigmatellin
complex from PDB 1pp9 [41] is 6.91 Å).
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from mitochondrial studies [25] in which the proton gradient
was varied through poising of the ATPase reaction. In the
chromatophore experiments, the development of both electron
transfer poise and proton gradient could be resolved kinetically.
In chromatophores, where superior kinetic resolution and
redox poising make it possible to separate out the partial pro-
cesses contributing to the Q-cycle, activation energies can be
measured or estimated for each of these within well-defined
constraints [26]. From such experiments, it was established that
the reaction at the Qo-site is rate limiting under conditions of
substrate saturation, and that it is responsible for the high
activation energy of the overall reaction. However, this reaction
is itself complex, and under non-saturating conditions, rates are
also in part determined by reactions involved in formation of the
ES-complex, and dissociation of products. A full understanding
of mechanistic detail therefore requires analysis of the partial
processes contributing to the Qo-site reaction [1,13,27], and their
structural context [26].
3. Movement of the ISP extrinsic domain—a dancer in the
Qo-site ballet
A surprise from the structures was the large-scale movement
of the extrinsic domain of the ISP [16], which is now recognized
as essential for delivery of electrons from the Qo-site to cyt c1
[28–31]. The role of this movement in control of the Qo-site
reaction has been the topic of much speculation. It seems clear
from molecular dynamics simulation [34] and from kinetic
measurements [14,35] that the movement itself is stochastic, and
so rapid as not to be rate limiting for the overall forward reaction
[32,33]. The critical issues for discussion therefore center on the
involvement of the ISP mobile domain in formation of transient
complexes with its reaction partners—with cyt b and the
occupants of the Qo-site (inhibitors, Q and QH2), or with cyt c1
and its heme [6,36–38]. Structures showing the reduced ISP
(ISPH) forming H-bonded complexes in situ with several Qo-site
inhibitors (stigmatellin, NQNO, HHDBT and UHDBT) occu-
pying the domain of the Qo-site distal from heme bL (the distal
domain), have been solved crystallographically [15,16,38–41].
The existence of such complexes was known from earlier bio-
physical evidence, and EPR spectroscopy [42,43]. In addition, it
had been early speculated that the EPR line at gx=1.80 reflected
an interaction of ISPH with quinone (Q) bound at the Qo-site,
and that QH2 also likely might bind in close association with ISP
in formation of the ES-complex [44]. Of these complexes, the
reactions involved in formation of the ES-complex at the Qo-site
are the most important in understanding mechanism [36,45–47],
but because these occur only under the metastable condition in
which oxidized ISP and ubihydroquinone are both present, these
are also the least accessible to direct observation and ther-
modynamic characterization.
4. Configuration of the ES-complex
Because the ISP extrinsic domain is mobile, it acts as a
diffusible second substrate (albeit, a tethered one) in the reactionat the b-interface, so that the binding of two substrates, ISPox
and QH2, is needed for formation of the ES-complex. Since an
electron is transferred from QH2 to ISPox, the ES-complex is
expected to form with QH2 close to the ISP docking interface.
The PDB file 1ntz has coordinates (with high B-factors) for a
quinone occupant, but the experimental basis for these has not
been discussed by the authors [48]. None of the other structures
currently available shows any quinone species bound at the Qo-
site. Modeling of quinone or quinol occupancy has therefore
been based on occupancy of inhibitors. Because the rate-limit-
ing reaction involves reduction of the oxidized ISP (ISPox),
requiring a relatively short electron transfer path, the most ob-
vious choice has been the stigmatellin structure, which shows a
direct H-bond between Nε of His-161 of the reduced ISP and a
carbonyl group of the occupant. A quinol modeled with H-
bonds to the same ligands as stigmatellin can replace the inhi-
bitor in the structure without strain, and fits within the electron
density of the inhibitor [41,49]; the quinone species modeled
in 1ntz is in a similar configuration. Models of this sort have
been the starting point for most discussions of the ES-complex
(Fig. 2) [36,49,50].
If a H-bond similar to that seen with stigmatellin, but from the
quinol –OH to His-161 of ISPox, is involved in stabilization of
the ES-complex, it would likely be to the imidazolate form
[51,52]. The relative pK values for quinol and ISPox would favor
an H-bond with the Nε of His-161 of ISPox in the dissociated
form as H-bond acceptor, and the quinol –OH as donor. This
configuration was suggested on the basis of the thermodynamic
properties, but required the assumption that the pK on the
oxidized form at 7.6 observed through redox titration of ISP was
associated with the histidine involved in H-bonding [51]. Re-
cently, Iwaki et al. [53] have shown that well-characterized
bands in the FTIR difference spectrum represent “the loss of the
imidazolate form of one or both of the Nδ-ligated imidazole
histidine ligands to the [2Fe–2S] center”, which are “in the
imidazolate form in the oxidized protein above pH 7.6, and …
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reduced”. This is the first direct confirmation of our earlier
interpretation.
The suggestion of such a H-bonded configuration opened the
possibility of an investigation of the binding energy involved
through the magnitude of thermodynamic effects assayed kine-
tically through formation of the ES-complex [46,47]. Since
formation of the ES-complex would, according to the above
hypothesis, pull both QH2 and ISPox out of solution, measure-
ment of these effects should provide two of the values needed to
complete the thermodynamic square describing formation of the
ES-complex (Fig. 3). The two effects assayed were the
displacement of the Em value of the Q/QH2 couple involved in
formation of the ES-complex [54–56], measured from the
apparent Em for QH2 oxidation, and the pH dependence of QH2
oxidation [57,58], interpreted as a displacement of the pK of
ISPox [46,47]. These had been reported in an extensive literature,
but had not previously been linked. Values reported for the
apparent Em of QH2 involved in formation of the ES-complex
are ∼40 mV more positive than that measured for the quinone
pool, while the apparent pK of ISPox assayed kinetically is ∼1.2
pH units lower than the value measured in redox titrations.
Within the range of measured values, these represent similar
free-energy contributions. A strong correlation between the
changes in apparent pK, measured from the pH dependence of
electron transfer, and changes in the measured pK of ISPox in
mutant strains, has provided firm support for the above hypo-
thesis [59]. Taken together with the FTIR evidence [53], the data
strongly support the suggestion that the dissociated form of His-
161 of ISPox is involved as H-bond acceptor in the ES-complex
with QH2.
Binding of QH2 in the absence of ISPox would involve other
binding forces, including that due to the H-bond in which the
second –OH of quinol participates. Using the binding of stig-
matellin as a model, this –OHwould mimic the second ligand of
stigmatellin to Glu-272 of cyt b (a member of the highly con-
served –PEWY– loop, numbered as in the chicken sequence),
with the carboxylate group as acceptor. The free-energy contri-
bution to binding could be estimated from the change in apparent
affinity of the QH2 substrate in mutant strains in which the
glutamate was changed to other residues, assayed through the
dependence of rate on [QH2]. This effect was quite small,
suggesting an approximately 2-fold change in Km [49]. AFig. 3. Binding square involved in formation of the ES-complex. Formation of
the ES-complex requires binding of two substrates, QH2 and ISPox. See text and
legend to Table 2 for explanation.binding constant for ISPox in the absence of quinol could be
estimated from crystallographic data [33]. The relatively weak
occupancy of ISP, as estimated from the electron densities rela-
tive to the rest of the protein in structures of the native complex
from different groups, was used to suggest that the affinity was
relatively weak for either the b-position, or the c-position [33].
These estimates provide constraints on the fourth value needed
for the thermodynamic binding square. The four values provide
the same overall ΔGo′, in the range ∼−8 kJ/mol (or 83 mV in
electrical units) from the sum of separate ΔGo′ terms, for
formation of the ES-complex by either pathway from vacant site
(left) to ES complex (right) of the thermodynamic square (see
Fig. 3).
5. The EP-complex
The EP-complex in which quinone interacts with ISPH has
been studied through several different approaches. As noted
above, the line at gx=1.80 in X-band CW-EPR depends on the
presence of both Q and ISPH. With the recognition from
ENDOR and crystallographic data that the histidine ligands to
the [2Fe–2S] cluster were exposed [60,61], several groups noted
the possibility, based on the involvement of histidines in ligation
of Q in bacterial reaction centers, that one of the histidines might
also serve as a ligand to Q in the Qo-site [62–64]. From more
detailed ESEEM studies, the hyperfine interactions of the Nδ of a
histidine (likely H-161 in bovine numbering) were shown to be
similar in the gx=1.80 and stigmatellin complexes, and different
from those seen when the complex was dissociated on addition
of myxothiazol [65]. Addition of myxothiazol or MOA-type
inhibitors, eliminated this band, presumably by displacing Q,
and also led to a change in Em of ∼−30 mVof ISP [45,66–69],
suggested to reflect the loss of the H-bond with quinone.
Interestingly, when similar experiments were performed using
mutant strains in which the linking sequence through which the
extrinsic head is attached to the anchoring N-terminal tail was
modified [37], the myxothiazol-induced change in Emwas much
greater, suggesting that additional forces had come into play
[69]. The simplest interpretation was a change in strength of the
H-bond arising from the closer proximity allowed by the
lengthened link [45,68], but orientation-selective EPR measure-
ments have suggested additional complications [67].
6. Forward electron transfer — the oxidation of QH2
Much discussion of the efficiency of the bifurcated reaction
has centered on “gating mechanisms” to prevent passage of both
electrons to the high potential chain. Two natural gating pro-
cesses are intrinsic to all Q-cycle mechanisms.
(i) The formation of the ES-complex will occur only under
the metastable conditions in which the QH2 substrate is
available, and the high potential chain is oxidized. Nor-
mally, this non-equilibrium state is generated only under
conditions appropriate for net forward electron transfer.
(ii) Under normal operation (“state-3” conditions in mitochon-
dria), the quinone pool is maintained at least partly
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since otherwise, the photochemistry would fail; similarly,
the dehydrogenases would be turned off if no Q was
available in respiratory chains. As a consequence, an
acceptor is always available at the Qi-site, so that the low
potential chain is partly oxidized, and hence can rapidly
remove the intermediate SQ product. Even under static
head (“state 4”) conditions, when the backpressure from
Δp is maximal, heme bL is about 50% oxidized [22–
24,72,82].
It is not widely appreciated that, because net forward
electron transfer can occur only when both conditions (ISP
and heme bL both oxidized) are satisfied, and net reverse
electron transfer when both ISP and bL are reduced, these
constraints represent an intrinsic double-gating in both
directions built into the Q-cycle. Under normal forward
conditions, the efficiency of bifurcation is high, and
bypass or short-circuit reactions [1,70–72,74] are negligi-
ble. Under static head conditions, heme bL becomes partly
reduced because of “back-pressure” from the proton
gradient, and a physiologically important bypass reaction
occurs, leading, in an aerobic system, to reduction of O2 to
form superoxide [72,82,83]. Bypass reactions of this sort
are also intrinsic to all Q-cycle mechanisms that involve
formation of a SQ intermediate. However, the bypass rate
is much greater when electron transfer to the Qi-site is
blocked, and these inhibited conditions are normally used
to study the reactions. It is estimated that the rate of
superoxide generation in antimycin-inhibited mitochondria
is ∼80% of the total cellular production of reactive oxygen
species [70–72,82], and such rates might apply in mutant
strains, or myopathies with mutations in the Qi-site. The
debate over how the complex has evolved to minimize
these bypass reactions can be framed in terms of the
following questions.
(iii) Are the rates of bypass reactions explicable in terms of the
intrinsic electron transfer mechanisms, or
(iv) are there are additional special gating mechanisms that
involve, for example, allosteric control, conformational
coupling, etc.
In order to explore these questions, it is necessary to establish
a minimal model for the mechanism of the site at the molecular
level.
7. Kinetic constraints on the reaction mechanism at the
Qo-site
Distances between redox centers involved in catalysis can be
measured from the structures. Empirical evidence and theoret-
ical considerations have suggested that distances determine the
“intrinsic” rate constant, ko, in the Arrhenius–Randall–Wilkins
treatment, kcat=koe
−ΔG#/RT. When expressed in log10 form, and
expanded to include a Marcus term for the activation energy,
and a Moser–Dutton [73] treatment of ko, this gives:
log10kcat ¼ 13 0:6ðR 3:6Þ  gðDGo þ kÞ2=k ð1Þwhere R is the electron transfer distance (the closest distance
between conjugate rings for cytochromes, chlorophylls, etc.), λ
is the reorganization energy. The factor γ is 4.23 (F/
(4×2.303 RT) at 298 K in the classical Marcus treatment, or
3.1 in the Moser–Dutton equation. This latter value reflects the
contribution of quantum mechanical corrections that were
applied to generate fits to experimental data. This useful equa-
tion can be applied to discussion of the mechanism of the Qo-site
in the context of the structure, since it provides constraints de-
termined by distances. For the Qo-site reaction, application
depends on the answers to three questions:
(i) What is the structure from which the reaction proceeds?
(ii) What is the nature of the reaction?
(iii) If the reaction is sequential, which of the two 1-electron
transfer steps is rate determining?
In the discussion of rates that follows, we will use theMoser–
Dutton equation (with γ=3.1), which gives increasingly higher
rate constants than the classical treatment as λ and –ΔGo
diverge. However, in most cases, plausible rate constants can be
calculated using either approach. In the discussion of bypass
rates below, the calculated SQ occupancy would vary depending
on choice of γ. Since subsequent calculations are “normalized”
to this occupancy, relative rates and occupancies will for the
most part show the same pattern, and lead to similar conclusions,
with either choice. Where anomalies occur they will be pointed
out.
From the considerations in the section above, the location of
the ES-complex with QH2 in the distal domain seems firmly
based, and this will provide the starting point for the remaining
discussion. In our view, and not withstanding recent suggestions
to the contrary [74,75], the evidence in favor of a sequential
electron transfer with an intermediate semiquinone product is
also overwhelming. Perhaps, most compelling is the demon-
stration that the overall rate is determined by the driving force for
the first electron transfer, and is relatively independent of the
driving force for the second electron transfer. The experimental
basis for the first conclusion comes from several different groups
who have reported mutations of ISP in which the redox potential
of the [2Fe–2S] cluster has been modified [26,52,59,76,77]. The
driving force is determined by the redox difference:
DGo V¼ zFðEmðISPÞ  EmðSQ=QH2ÞÞ:
It seems unlikely that mutations in the ISP cluster-binding
domain would affect the Em of the semiquinone couple. If
Em(SQ/QH2) is unaffected, changes in Em(ISP) would be directly
reflected in changes in the driving force. After normalization to
the wild-type rate, the results from separate studies crossing the
bacterial/mitochondrial divide, and different genera of bacteria,
have shown the same behavior, all data falling on the same
curve of log10ko v. ΔG
o′, which can be well fitted by a classical
Marcus curve [47]. In contrast, no such relationship has been
reported for mutations changing Em(heme bL), although mutants
have been reported from several labs (cf. [26,36,78]). Similarly,
the ∼60 mV change in Em of heme bL on reduction of heme bH
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activation energy.
Hong et al. [26] suggested that determination of kcat from
distances in the structures could be used to put constraints on
reactions at the Qo-site, based on the simple kinetic relationship:
v ¼ kcat½occupancy ð2Þ
They evaluated a number of different mechanisms, and
concluded that, in the context of an ES-complex formed at the
distal end of the pocket, viable schemes could be limited to three
types:
(i) The intermediate SQ product was constrained to the distal
domain, for example by a relatively stable ISPH.SQ
intermediate product [41,79]. In this case, a relatively high
occupancy was required for overall forward chemistry at
the observed rate because of the limitation on the rate
constant for the second electron transfer arising from the
long distance to the acceptor, heme bL.
(ii) The SQ product was liberated by dissociation of the ISPH
after the first electron transfer, and could move within the
volume of the Qo-site [36,49]. Hong et al. [26] favored
this mechanism because of the need to minimize harmful
short-circuit reactions by keeping [SQ] occupancy to a
minimum. Because the rate constant is higher at shorter
distances to the acceptor heme bL, the observed rate could
be attained at much lower SQ occupancy.
(iii) Double occupancy of the Qo-site by two quinones [44,80],
arranged so as to bridge the distance between ISP and
heme bL, would also provide a mechanism allowing a
higher rate constant for transfer of the second electron, and
hence allow a lower occupancy. However, as discussed at
length elsewhere, the failure to find in the kinetic behavior
or the structures the properties expected was seen as
problematical [26,36].
Among mechanisms rejected were all those in which the two
electron transfers occurred from a common activated state, since
only one of the two steps, the first electron transfer, showed
control by driving force.8. The first electron transfer from QH2 to ISPox
Identification of the first electron transfer as the limiting
process raised the question of why this reaction was so slow. As
shown in Fig. 2, the electron transfer distance is <7.0 Å, which,
with conventional parameters for driving force and reorganiza-
tion energy (λ) in the Moser–Dutton equation, would be
consistent with a rate in the sub μs range rather than the 1.3×103
s−1 observed. The “theoretical” rate could be “slowed” by
assuming both a strongly endergonic first electron transfer, and a
large value for λ, consistent with the high activation barrier [26].
However, the reaction interface provided no obvious explana-
tion for the high activation barrier. From the nature of the
proposed ES-complex, and the redox properties of the reaction
partners, it was apparent that a proton transfer must be coupled tothe electron transfer reaction, and this insight leads to a more
satisfactory explanation. The pK values for QH2 and ISPox
determine the probability for proton transfer along the H-bond
joining them, through a Brønsted term, ΔGo′=2.303 RT
(pKdonor−pKacceptor). Use of the measured pK values, together
with the overall free-energy, allowed construction of a
thermodynamic cycle from which the probability of different
pathways could be assessed. The likely sequence in the reaction
is the pathway involving the transfer of a proton first, then the
electron; the electron transfer occurs from a proton configuration
that is kinetically favorable, but thermodynamically improbable
[46,81]. The proton transfer step is strongly uphill (ΔGo′=21–
27 kJ/mol), and contributes about half the activation barrier. The
remaining barrier is that for the electron transfer itself. This has a
driving force closer to the isopotential range, and can occur with
conventional reorganization energy and rate constant. The ob-
served rate is slow because transfer occurs from a very low
occupancy of the kinetically favorable proton configuration
[47].
Rates of proton transfer along H-bonds can be extremely
rapid (in the range 1011 to 1013 s−1). Even allowing for the
strongly unfavorable equilibrium constant, rate constants in
both directions will be much more rapid than the overall
electron transfer rate, so the contribution of the proton
barrier can be treated using a simple kinetic expression,
kapp=kETKproton. Expansion of the Moser–Dutton equation to








 pKQH2  pKISPox
 
:
9. Role of the pK of ISPox in determining rate
An interesting consequence of this treatment is that the pK of
ISPox has two roles to play in determining the rate of reaction.
One is through the Brønsted term in the above equation. An
additional contribution, as noted above, arises from the role of
the dissociated form of ISPox as the substrate involved in
formation of the ES-complex, and dependence of the concen-
tration of this form on pH and pK. The probability of forming
ES is dependent on pK. These different roles can be explored
through use of mutant strains in which the pK is modified.
Raising the pK, as in strain Y156W [47,59], with pK changed
from 7.6 to 8.5, leads to a change in the pH dependence of
electron transfer to the higher value expected from the role in
formation of ES. However, the higher pK would be expected to
lower the Brønsted barrier, and therefore lead to a higher rate
constant. This effect is also observed, though convoluted with
the change linked to the change in driving force arising from the
changed Em. Because the two changes have opposing effects on
rate, the net result is that at any fixed pH below the pK, the rate
appears to depend only on the Em value, as observed [59].
Further exploration of this relationship with new mutant strains
in which Ser-154 is modified support these conclusions
(SangMoon Lhee and ARC, unpublished).
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The second electron transfer involves oxidation of the SQ by
heme bL. Examination of the available structures showed
several features that provided clues to the mechanism [36,49].
(i) The volume of the site was larger than necessary to acco-
mmodate the QH2 substrate.
(ii) Inhibitors were bound in different but overlapping do-
mains; the H-bonding of stigmatellin by ISP constrained it
to the domain distal from heme bL, but myxothiazol and
MOA-type inhibitors were bound more proximal to heme
bL.
(iii) Glu-272 was in different positions in different structures,
either pointed towards the distal domain to act as a second
ligand to stigmatellin, or rotated by >130°, to point to-
wards heme bL in the native structure, or those with pro-
ximal domain inhibitors.
(iv) Residues changed in strains resistant to myxothiazol but
not to stigmatellin lined the myxothiazol binding domain
as expected, but changes at these positions correlated with
two additional properties of mechanistic interest; (a)
electron transfer was inhibited, but (b) the binding of Q to
ISPH indicated by EPR signal at gx=1.80 was not. These
effects were interpreted as showing that in these strains,
binding of quinone species (including QH2) at the distal
domain was unimpeded, but that occupancy of the pro-
ximal domain was blocked, and that such an occupancy
by some intermediate was necessary during turnover.
On the basis of these properties, and of changes on muta-
genesis of Glu-295 (the equivalent of Glu-272 in Rb. sphae-
roides), Crofts et al. suggested a mechanism in which the SQ
could move in the site closer to heme bL (Fig. 4) [34,36,49].
Molecular dynamics simulations had revealed a buried water
chain to which the glutamate connected in the rotated position.Fig. 4. Configurations of the Qo-site involved in electron transfer. In A, the configurat
through the 7 Å distance shown between QH2 and the 2Fe–2S cluster of ISP, with
intermediate QHU− would be in a similar configuration, but with the reduced 2Fe–2S
In B, the mobilized SQ has passed a proton to the –PEWY– glutamate (Glu-272 in c
group contacts a water chain leading to the P-side aqueous phase. The QU− is now clos
SQ suggested (see text).The rotation of Glu-272 therefore provided a mechanism for exit
of the second H+ from the site. An additional point was that, with
a shorter distance to heme bL, the necessary rate could still be
achieved at a lower occupancy of SQ.
As Hong et al. [26] pointed out, several critical parameters
needed to assess this mechanismwere unknown, in particular the
SQ occupancy, and the distance over which electron transfer
occurs. Osyczka et al. [75] introduced the idea that the occu-
pancy of SQ could be estimated from the rate of short-circuit
reactions, since all of them involve SQ as an intermediate. This
approach, and the earlier arguments of Hong et al., now make it
possible to determine important constraints on mechanism that
allow a choice between the options previously discussed [26].
The problems can be summarized through the terms in Eq. (2) –
occupancy, rate, and rate constant – the latter provided by the
distances through which electron transfer reactions involving
SQ might occur (Fig. 5). Starting with a SQ in the distal position
(Fig. 5A), where it would be formed from an ES-complex of the
sort discussed above, evolution of the state of the system under
“bypass-conditions” (forward electron transfer inhibited because
heme bL is reduced), can occur through several pathways that
lead to loss of the SQ [5,22,75]. Muller et al. [5] showed that the
dominant pathway (∼70%) was by oxidation, either by O2 under
aerobic conditions, or through the high potential chain (ISP,
heme c1, cyt c) under anaerobic conditions. Because cyt c can
rapidly oxidize the superoxide generated under aerobic condi-
tions, both pathways could be assayed through the reduction of
cyt c in the presence of antimycin. Oxidation under anaerobic
conditions necessarily requires the dissociation of the interme-
diate product (ISPH.SQ) after the first electron transfer, because
movement of the ISPH is necessary for reduction of heme c1 [5].
The immediate oxidant for SQ is ISPox on its return from
delivery of an electron to cyt c1. It is assumed that ISPox accepts
electrons from the same position as in the ES-complex, through a
distance of ∼7.0 Å. It is likely that O2 reacts through a similar
distance, since the docking site for the ISP would provide anion before transfer of the first electron is shown. The first electron transfer occurs
the constraints discussed in the text. Immediately after the electron transfer, the
cluster dissociated so as to liberate both ISPH and SQ for subsequent movement.
hicken numbering), the side chain of which has rotate so that the carboxylic acid
e enough to heme bL to deliver an electron rapidly, even at the low occupancy of
Fig. 5. Parameters determining electron transfer rates under bypass conditions.
The ubiquinone and protein configurations in panels A and B are the same as for
Fig. 4A and B. In panel C, the SQ is shown in the position expected from the
constraints of coulombic gating suggested in the text. The 12.4 Å distance from
SQ in the distal domain to heme bL is based on the crystalographically-
determined position of UHDBT (1sqv), while the 6.3 Å distance from SQ in the
proximal domain to heme bL is based on the position of myxothiazol (1sqp).
These values are used for compatibility with the discussion of Osyczka et al.
[74]. The notes inserted in the figure report the rate constants, occupancies and
rates as follows: (a) The rate constant for oxidation of SQ by ISPox calculated
from the 7 Å distance and appropriate values for ΔGo and λ, and the occupancy
of SQ needed to match the observed rate of ∼ 3 s− 1. (b) The rate constant
calculated using the 12.4 Å distance, and the rate of electron transfer for the 2nd
electron at the occupancy in (a). (c) The rate constant calculated using the 6.3 Å
distance, and the rate of electron transfer for the 2nd electron at the occupancy in
(a). (d) The rate constant calculated using the 6.3 Å distance, and the rate of
reduction of SQ by heme bL
− at the occupancy in (a), if SQ were at the proximal
position. (e) The rate constant calculated using the 12.4 Å distance, and the rate
of reduction of SQ by heme bL
− at the occupancy in (a), if SQ were restricted to
the distal position by coulombic gating.
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provide a value for the distance in the Moser–Dutton equation,
allowing calculation of a plausible rate constant. From the
measured rate and Eq. (2), we should now be in a position to
calculate occupancy. Osyczka et al. [75] discuss the problem in
terms of the stability constant for SQ formation under equi-
librium conditions,Kstab. This provides a measure of occupancy/
bc1 complex through [SQ]=(0.25 Kstab)
1/2, but is otherwise not
relevant to the Qo-site mechanism. Using the ∼7.0 Å distance, a
rate for bypass of ∼0.3 s−1 measured from the decay of reduced
heme bL, a driving force for electron transfer from SQ to ISPox of−0.5 V, and a conventional value for λ ∼1 V, they calculated an
occupancy in the range 5×10−9 SQ/bc1 complex. The rate of
electron transfer from SQ in the distal domain to heme bL at this
occupancy, which would determine the net rate of forward
electron transfer, would be ∼0.25 s−1, clearly inconsistent with
the measured forward rate of 1.3×103 s−1 [26]. The rate of
bypass measured by Osyczka et al. (∼0.3 s−1) was 10-fold
slower than rates commonly reported in the literature [71]. The
latter are measured under “oxidant-induced reduction” condi-
tions, with the two b-hemes completely reduced, which might be
expected to maximize SQ occupancy. In estimation of the
operational SQ occupancy under conditions of normal forward
electron transfer, we have to keep in mind the possibility of
gating effects from the heme. If we ignore such effects, the SQ
occupancy would likely be lower than that calculated from
maximal bypass rates because the rate constant for SQ removal is
higher than for formation. However, using a bypass rate of
3.0 s−1 [5], in the range commonly reported, giving an occu-
pancy ∼4×10−8, the calculated rate for transfer of the second
electron would still be 3 orders of magnitude slower than the
observed forward rate (Fig. 5A a, b). In order to achieve the
measured rate, an occupancy in the range >10−5 SQ/(bc1
complex) would be needed. However, and here's the problem,
this would be expected to allow rates for bypass reactions similar
to those for forward chemistry, and would lead to massive in-
efficiency in proton pumping. We can endorse the conclusion
reached by Osyczka et al. “Thus, there is no single value of Kstab
that will permit rapid sub-millisecond forward and reverse
electron tunneling and simultaneously limit short-circuit tun-
neling to the timescale of seconds” [75], and recognize the need
for some gating mechanism.
The suggestion that the SQ might move in the site [26,36,49]
provides some escape from this paradox. Using the SQ occu-
pancy of 4×10−8 calculated from the observed bypass rate, the
change in rate constant for the electron transfer from SQ to heme
bL obtained by changing the distance from 12.4 to 6.3 Å, allows
for a >1000-fold increase in rate, to a value greater than the
observed rate (Fig. 5B(c)). However, we are now forced to
consider possible consequences of allowing the SQ close to
heme bL, and the potential for short-circuit by other bypass
reactions, such as those involving direct reduction of SQ by
reduced heme bL [1,5,22,74]. Given the Em values of heme bL
(−90 mV) and the SQ/QH2 couple (likely >400 mV), the
reaction would be strongly exergonic, and would occur over a
short distance, leading, at the occupancy proposed, to a calcu-
lated bypass rate similar to the forward rate (Fig. 5(d)). Similar
scenarios can be demonstrated for other positions because no
matter what particular position we choose, rates for forward,
back, and bypass reactions are in the same range, leading to
prediction of crippled proton pumping efficiencies.
11. Mechanisms that prevent accumulation of SQ
In view of these difficulties, it is not surprising that Osyczka
et al. [74,75] would suggest that mechanisms allowing
accumulation of SQ should be discarded. However, this may
be a case of throwing the (SQ) baby out with the bath-water— a
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reactions do involve SQ generated at the Qo-site [5,71,72,83].
Before this approach can become acceptable, plausible hypo-
theses to account for the anomalies in terms of mechanisms that
prevent SQ accumulation will be needed. The recent literature
has spawned a plethora of options, including concerted mecha-
nisms [27,84–86], and gated mechanisms involving indirect
effectors operating on several different players [58,79,87–90].
Osyczka et al. [74] rejected all current schemes, and considered
two possibilities of their own; (a) a concerted process in which
both electron transfers occurred from a common intermediate at
the activation barrier, and (b) a double-gated mechanism in
which SQ was generated only under circumstances in which it
was immediately consumed. However, both these proposals are
problematical, as discussed more extensively below.
11.1. Concerted mechanisms
Hong et al. [26] had previously considered the evidence
against some concerted mechanisms, and the points they raised
are still valid. These and other difficulties can be summarized as
follows:
(i) In a concerted reaction of the sort proposed, both electron
transfers would have to occur at the same rate. If both
electron transfers occur from a common activated state,
then both would have to have the same intrinsic rate
constant, ko, and the same control by driving force. From
the lack of control in the second electron transfer, this is
clearly not the case.
(ii) Similarly, the distance for transfer of both electrons to
their separate acceptors would have to be about the same,
with similar structure intervening between the QH2 donor
and the two different acceptors. Neither the location for
the reaction complex roughly midway between ISPox and
heme bL, nor the structural similarity, has any justification
from crystallographic data.
(iii) Separation of two electron charges from QH2 in a phase of
relatively low dielectric would entail obvious physical
problems. It is therefore necessary to address the question
of the co-transfer of protons required by the overall re-
action equation, and the synchronization of these pro-
cesses with the electron transfers. No consideration was
given to these aspects.
(iv) The exponential term in the Arrhenius equation provides
an estimate of the occupancy of the activated state. Under
conditions of substrate saturation, kcat=koexp(–ΔG
#/RT)
≈ ko[ES#]. This is because, in the standard treatment,
–ΔG#/RT= lnK#, and K# = [ES#]/[ES], so that [ES#]
becomes equal to the fractional occupancy of the activated
state if [ES#]<< [Etot]. For an activation energy of
∼600 mV, occupancy would be ∼10−10. Applying Eq.
(2) to this occupancy shows that a rate constant∼1013 s−1
is required to give the observed rate. This is the value
expected when the reactants are at van der Waals contact.
No plausible configuration of the Qo-site would allow both
electron transfers to occur from such a distance.(v) It is clear in any scenario that if the activated state is
generated in the distal domain, electron transfer to heme
bL could not occur at a realistic rate at this occupancy
[26].
(vi) Recognizing that the constraint suggested by this sim-
plistic treatment might be too harsh, there are still prob-
lems even with the most permissive scenario. For a
reaction complex midway between ISPox and heme bL, the
rate constant calculated using the Moser–Dutton equation
with λ=2.0, R=9.6 Å, andΔGo =0, is kcat ∼1.4×103 s−1.
This is just adequate for concerted electron transfer from
a fully occupied ES-complex in this position. However,
such a scenario is difficult to justify. None of the
structural or kinetic evidence discussed above is compat-
ible with such a position, and the plausibility of the
calculated rate constant depends on quantum mechanical
corrections (implicit in the γ=3.1 of the Moser–Dutton
treatment) to “lower” the barrier. With a classical Marcus
barrier, this configuration gives rate constants 100-fold
too slow.
(vii) An earlier mechanism discussed by Crofts and Wang [27]
involved a SQ intermediate at the occupancy of the
activated state, and is formally equivalent to a concerted
reaction, since the second electron transfer occurred from
this state. A similar mechanism was more recently dis-
cussed by Kim et al. [90]. The slope of the Marcus curve
expected is much steeper than observed, and on this basis,
mechanisms of this class were excluded [26].
11.2. Double-gated mechanisms
The discussion of how double-gated mechanisms might
function [74,75] has been framed in rather general terms so as to
allow formation of SQ only if both chains were oxidized and
QH2 was available as substrate for the forward reaction, or both
chains were reduced and Q available as substrate for the reverse
reaction (see above). In either case, the SQ would always be
rapidly removed on formation, so as to keep the occupancy low.
There is no objection in principle to double-gating, since it is
intrinsic to the Q-cycle mechanism. However, the mechanisms
proposed by Osyczka et al. [74] were rather lacking in detail,
and it was not clear what additional mechanistic components
would be necessary to forestall bypass reactions, for instance
under “oxidant-induced reduction” conditions. Rich [95] has
discussed some specific “logic-gated” mechanisms, including
gating functions linked to the redox state of the b-hemes, that
would prevent binding of QH2 or formation of SQ [84,96], but
Osyczka et al. [75] preferred the more general framework. In
neither case were particulars included that might be tested
experimentally. The structural context was weakly defined, and
the evidence discussed above for specific features (such as the
configuration of the ES-complex with a direct H-bond from His-
161 of ISP, and a direct H-bonding role for Glu-272) was
ignored. Instead, participation of waters as H-bonded bridges
between the quinone species and unidentified ligands was
proposed [75]. No evidence for such a configuration is avail-
able. The authors did not suggest experimental tests, except in
Table 1
Electron transfer rates for forward and bypass reactions at the Qo-site in wild







WT 1.35 237 0.6
E295W 1.5 2.0 75
E295L 2.8 7.18 39
E295G 1.46 2.7 54
E295Q 1.76 9.8 18
E295D 1.56 14 11
E295K 1.25 3.2 39
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reactions they measured. This argument was weakened by the
fact that the rates they reported were 10-fold lower than those
measured elsewhere.
The types of mechanism proposed by Osyczka et al. [74,75]
would be expected to prevent significant occupancy of SQ, so
neither accounts for the bypass rates that are observed, or the
properties of these reactions that have led others to recognize
that a SQ is involved. A plausible scheme in either the concerted
or the double-gated scenario would therefore need to be supple-
mented by additional hypotheses.
12. Coulombic gating
An alternative approach is to look for explanations in the
context of mechanisms in which SQ is a natural intermediate. A
promising starting point is the mechanism involving mobility of
the SQ in the site [36,49]. If the SQ could be prevented from
getting close to reduced heme bL, the troubling short-circuit
reactions associated with that configuration would be avoided.
The mechanism summarized in Figs. 4 and 5 shows a gating
process that is a natural consequence of the chemistry. It involves
the other dancer in the Qo-site ballet – Glu-272 – previously
proposed as a proton-carrying group involved in getting the
second proton out of the Qo-site [36,49]. The pirouette of Glu-
272 was apparent in early structures from Berry's group [16,32].
In the stigmatellin structure PDB 2bcc, it was involved as a
ligand to the inhibitor. In contrast, in the native structure PDB
1bcc, or in the presence of myxothiazol [36], the side chain was
rotate around by >130° to connect to a chain of H2O molecules
leading to the aqueous phase. This water chain was first iden-
tified in amolecular dynamics simulation of ISPmovement [34],
but has now been seen in higher resolution structures of bc1
complex from yeast [50] and bovine mitochondria [41]. The
initial configuration in the mechanism suggested started with the
ES-complex discussed above (Fig. 4A). After the first electron
transfer and dissociation of ISPH, a neutral SQ, QHU, was left at
the distal end of the site, H-bonded to the Glu-272 carboxylate
side chain. After H+ transfer from QHU to glutamate, the side
chain rotated to release the H+ to the water chain, leaving a SQ
anion, QU−, free in the site. We assumed that with heme bL
oxidized, QU− could diffuse to the proximal position, and
transfer the electron to heme bL (Fig. 4B). However, as noted in
[36], if heme bL were reduced, the net change in local negative
change would have coulombic consequences—the QU− would
be repelled. This would have two effects, (a) the reaction leading
to formation of the anionic form (on transfer of the secondH+ out
of the site) would by discouraged, and (b) coulombic repulsion
would prevented any QU− formed from getting close to heme bL−.
The SQ would then be restricted to the neutral QHU form,
constrained to the distal domain (Fig. 5C)—just what is needed
to prevent the rapid short-circuit reactions. These coulombic
effects therefore provide the gating necessary to minimize by-
pass reactions while allowing rapid forward and reverse
chemistry. The coulombic gating we have proposed functions
in the context of a mechanism that requires formation of SQ,
albeit at very low occupancy. This is in contrast to the suggestionof Osyczka et al. [75], where the gating was proposed to prevent
formation of SQ.
13. Mutational experiments to test the role of the
–PEWY– glutamate
In the mechanism proposed, Glu-272 obviously plays an
important role. We have previously reported experiments on
strains in which the equivalent residue (Glu-295) in Rb. sphae-
roides was mutated to glutamine, glycine, or aspartate in strains
E295Q, E295G and E295D, respectively [36,49]. All strains
showed substantially inhibited electron transfer through the Qo-
site, resistance to stigmatellin, and a modest increase in Km for
QH2. The E295Q, E295G strains (the E295D strain was not
tested) also retained a normal gx=1.80 EPR signal, diagnostic of
an uninhibited reaction of Q with ISPH at the b-interface. These
properties were consistent with the mechanistic role for the ES-
complex proposed.We have recently regenerated these and other
mutations in a His-tagged background to facilitate spectroscopic
studies. We have compared the bypass reactions in these strains
with wild type under conditions designed to minimize artifacts,
and we show preliminary results and example traces in Table 1 and
Fig. 6. Several features of the results are noteworthy, and provide
strong support for the coulombic gating mechanism proposed.
(i) It is clear from Table 1 that all strains showed bypass rates
similar to or greater than those seen in wild type.
(ii) It will also be obvious that all mutant strains showed a
strongly inhibited forward electron transfer. However, just
as important is the fact that none showed the complete
inhibition seen with mutations at other essential residues.
Each of these features is interesting. The bypass rates show
clearly that SQ was being produced in all cases, at occupancies
similar to or greater than in wild type under bypass conditions.
Yet the inhibited rates show that the SQ was unable to reduce
heme bL at the wild type rate. It is not clear what extent of
inhibition the measured rates represent, because, as argued at
length by Hong et al. [26], the rates for the second electron
transfer in the absence of Qo-site inhibitor are not rate limiting. In
the presence of antimycin, the rate of reduction of heme bL, seen
when heme bH is pre-reduced is essentially the same as the rate of
reduction of heme bH [97], despite that fact that the driving force
differs due to the coulombic effect, which lowers the Em of heme
bL by ∼60 mV. In addition, the activation barrier for both
Fig. 6. Turnover of the Qo-site in wild type and E295Wmutant on flash activation of the bc1 complex. Kinetic traces showing the changes in cytochromes and reaction
center on flash illumination of strains with wild type sequence (A and C) or mutation of Glu-295 to Trp (E295W) (B and D). The traces in A and B are following
illumination with a single flash, on a rapid time scale. Those in C and D are following a group of 6 flashes spaced at 10 ms. For cytochrome changes (heme bH in green,
heme bL in blue, heme c1 in red), an upward deflection shows reduction. For reaction center (RC, in black), an upward deflection shows oxidation. All traces were
measured in the presence of antimycin to inhibit oxidation of heme bH. In the presence of myxothiazol, the flux through the Qo-site was <0.3 electrons/bc1 complex/s
(not shown). The dashed lines show slopes used to measure rates. The wild type used was a mutant strain (E295K) that had reverted to wild type, to control for all
genetic engineering manipulations, but the behavior was essentially the same as His-tagged wild type. Experimental protocols were as previously reported [1], and
mutant strains were generated using conventional procedures [46,59]. Strain E295Wwas grown under anaerobic photosynthetic conditions in a medium supplemented
with DMSO so as to allow growth without limitation by the mutation.
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was apparent from this step, the rate must be fast enough that any
slowing due to the change in driving force is not reflected in the
observed rate [26]. Under the conditions of the experiments in
Table 1, the reaction was limited by the relatively oxidized state
of the quinone pool, but the intrinsic limitation was in the first
electron transfer step, as discussed above. In wild type, with an
unconstrained second electron transfer, a rate (determined by
rate constant and occupancy as discussed above) in the range
>10-fold higher than that for the first step seems reasonable, or
>104 s−1. The observed rates in the mutant strains therefore
likely represent a much more substantial inhibition than is at first
apparent. Remarkably, the rates observed are in the range
expected from electron transfer from the distal domain at the
occupancy calculated from the bypass rate (see Fig. 5), as
discussed more extensively below.(iii) In Fig. 6, example traces of the kinetics of reaction center
(RC) and cytochrome changes following flash excitation
of chromatophores from a strain with wild type sequence,
and in E295W, one of the more severely inhibited strains,
are shown. The kinetics observed show clearly that, in
both mutant and wild type strains, the distribution of
electrons in the high and low potential chains is
controlled by the equilibrium constants, as previously
demonstrated [12]. That for the Qo-site reaction controls
the overall distribution with respect to the quinone pool.
In all cases, the Qo-site reaction is observed through the
“oxidant-induced reduction of cyt b” [8], which is
initiated when, with QH2 available in the pool, oxidizing
equivalents from the RC, generated on flash illumination,
reach the Qo-site via ISPox. In Fig. 6A and B, the strongly
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In all reaction equations, E stands for enzyme, and represents the Qo-site in
cytochrome b.
A Visual Basic program, Marcus–Bronsted, which allows the user to explore
how the Marcus curves for the two electron transfer reactions at the Qo-site vary
with different parameters for driving force, SQ occupancy, pK of ISPox, etc., is
available for downloading from the URL below. Files available include the
program in executable (.exe) form, and all source code files needed for
compilation, together with an illustrated user manual.
http://www.life.uiuc.edu/crofts/Marcus_Bronsted/.
a The value in electrical units is derived from apparent binding constants.
Several possible ways for normalization to concentration are discussed in [47].
b From ΔGo=2.303(RT/F)(pKdonor–pKacceptor), using 11.3 for pKquinol, and
6.3 for pKISPox(bound). This latter value is appropriate for the pK of the form
bound in the ES-complex [47].
c Assuming ΔG#overall=660 mV from the ES-complex [26].
d The energy level of the intermediate product is uncertain. The main
constraint is the value used for rate constant, determined by the position from
which the SQ transfers its electron. From myxothiazol to the nearest conjugate
atom of heme bL is ∼6.3 Å, and a quinone modeled to occupy this position has
a similar distance. A closer position for Q can be found (with a similar energy,
after minimal side chain displacement) at a distance of 4.7 Å, giving a 10-fold
faster rate constant. The higher energy level shown here corresponds to the
occupancy of 4×10−8 discussed in the text. Choice of a value for ΔGo for this
intermediate state propagates to the other values indicated by a superscript d
[26].
e These values are somewhat arbitrary, but reflect relatively small equilibrium
constants, based on the difference in Km for O2 in production of superoxide for
antimycin and myxothiazol inhibited yeast complex [5].
f From the Em values for ISP and cyt c1 [12–14].
g The sum of free energies for the first and second electron transfers is
constrained by the ΔGo for the overall reaction, given by the Em values, using
ΔGo′/F=− (Em(ISP)+Em(hemebL)−2Em(Q/QH2))∼−30 mV [12].
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presence of antimycin following a single flash. In wild
type, the reduction is substantially complete at 40 ms but
in the mutant, barely detectable. If six flashes are given to
fully oxidize the reaction center and maximize the
driving force available in the high potential chain (Fig.
6C and D), and the time of measurement is extended,
additional features are apparent, and a more complete
reduction of heme bH can be observed in themutant. Note
that, in the rise kinetics for both strains, the reduction of
heme bL lags that of bH, as expected from the difference
inEm values. This lag is apparent in the wild type strain in
Fig. 6A, where no reduction of heme bL was seen after
the first flash, but heme bH was rapidly reduced. The
reduction of heme bL on the second and subsequent
flashes can be readily seen if the time scale in Fig. 6C is
expanded (cf. [97]). In the E295W mutant (Fig. 6D), the
turnover of the Qo-site is so slow that the reaction has not
yet come to equilibrium at the time of the last flash, and
the traces showing reduction of both heme bH and bL
continue to rise, the former even out until 4 s. However,
as the high potential chain relaxes, with RC and then cyt c
going re-reduced, the controlling effect of the Qo-site
equilibrium constant can be seen, leading to the re-
oxidation of heme bL before any relaxation of heme bH.
Essentially, the same relaxation effects can be seen in the
wild type (Fig. 6C), but they start from the higher level of
reduction of the b-heme chain achieved by the end of the
flash sequence.
It is clear from these results that in both wild type and
mutant, the equilibrium constants controlling the kinetic effects
are similar, but that both forward and reverse rate constants are
inhibited in the mutant strain. Similar effects were observed for
all mutant strains [1].
(iv) The bypass rates were measured from the flux of
electrons into the terminal acceptor of the high potential
chain, the oxidized reaction center, immediately after
the last flash of the sequence. At this point in the kinetic
trace, heme bH and heme bL were essentially completely
reduced in the wild type; in the mutant, heme bH was
∼80% oxidized and heme bL was almost completely
oxidized. Intermediate levels of reduction of heme bL
were seen in less severely inhibited strains [1]. Since the
SQ was likely the source of electrons in all cases, we
can say that the redox state of heme bL determines
neither the binding of QH2, nor the formation of SQ.
From this, it seems likely that neither the docking of,
nor the electron transfer to, ISPox are modified by the
redox state of either b-heme, and that we can excluded
any specific dependence on redox state of the b-hemes
in gating of these partial processes.
The behavior summarized above is readily explained in
terms of the hypothesis proposed here. The mutation of Glu-
295 frustrates the proton exit mechanism for the second
proton. This constrains the SQ to the neutral form, QHU,and to the distal domain, and likely also constrains Q to the
distal domain. The electron transfer rates from the distal
domain are limited by the greater distance to heme bL. From
the distances, we might expect the rate constants to change
by a factor of ∼ 1000, as discussed above, but both forward
and reverse rate constants would be changed by the same
ratio, since the determining factor will be the same
difference in distance between the occupant in distal and
proximal locations and heme bL.
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In this review, we have discussed the evidence that supports a
simple mechanism for the Qo-site of the bc1 complex,
summarized in the partial reactions of Table 2, for which all
necessary thermodynamic and kinetic values are given. The
mechanism accounts for the experimentally observed properties
of the Qo-site as it functions in the bc1 complex of Rb.
sphaeroides. All components of the mechanism are natural, and
have been derived from measured properties of the system. In
addition to the reaction properties, the mechanism requires
certain structural features, which have all been based on known
structures. The same mechanism accounts for most of the data
from mitochondrial studies.
This simple mechanism is by no means generally accepted.
Other groups have interpreted their data as showing mechanisms
that are more complex. These include interactions between
redox groups over substantial distances through postulated
conformational changes. For many of these mechanisms, some
features have been shown to be untenable in the context of the
Rb. sphaeroides complex [26,75], and our experiments with
Glu-295 mutants provide additional constraints. However,
evidence for long-range interactions between Qo- and Qi-sites
in both mitochondrial and bacterial complexes has come from
structures [39,91], and from a recent EPR investigation of the
configuration of the ISP mobile domain at the Qo-site on inhi-
bition or mutagenesis at the Qi-site [92]. Similarly, in our own
hands, mutations at the Qi-site designed to make the Rb. sphae-
roides complex sensitive to funiculosin (V209A and V209A-
I213L mutant strains), generated sensitivity, but at the Qo-site
(Sangjin Hong and ARC, unpublished results). The mechanistic
significance of these long-range effects is uncertain, since no
kinetic control arising from such interactions has been demon-
strated. On the other hand, it has been demonstrated that the rate
of oxidation of QH2 on a single turnover is unaffected by binding
of antimycin [14], and that binding of antimycin has no effect on
the configuration of the Qo-site detectable in the highest reso-
lution structure (2.1 Å) yet reported [93].
It is as well to recognize that the evolutionary divide between
bacteria andmitochondria represents∼2 billion years of separate
evolution, and is evidenced on the mitochondrial side by a
substantial increase in structural complexity following incorpo-
ration into the eukaryote cell. This has presumably reflected
some functional purpose. It is tempting, therefore, to ascribe the
differences between mitochondrial and bacterial complexes to
the greater structural complexity of the mitochondrial com-
plexes, and the fine-tuning of mechanism to fit the complex to its
eukaryotic role. On the other hand, some of the apparent
differences between bacterial and mitochondrial systems might
reflect difficulties in working with the latter. Most work reported
has been using the solubilized mitochondrial complexes in
stopped-flow experiments using unnatural quinone substrates.
The time resolution is not as rapid as that available through
photoactivation in chromatophores, and in most work, no
attempt has been made to measure the separate kinetic
contributions of the two b-hemes. The use of unnatural qui-
nones, especially apparent in earlier work, introduces differentdriving forces, and may also lead to different contributions of
bypass reactions [94]. Even when a good analog such as decyl
ubiquinone is used, limitations are introduced by the low critical
micellar concentration (<20 μM, [98]). These deficiencies, and
the uncertainty of some of the values for redox potentials of
centers in the yeast complex, mean that it has not been possible
to analyze the data with the precision needed to discriminate
between hypotheses. It might be as well to defer argument until
constraints from data are better established. On the other hand,
there is an old adage, “The heat of the controversy is inversely
proportional to the hardness of the data”; despite the caveat, 45
years for one of us (ARC) in the bioenergetics field has shown
that the controversy is half the fun.
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